PA SB 628

in committee

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for misbranding.

Pennsylvania · 2025-2026 Regular Session (209th General Assembly) · upper

Quick answers

Did PA SB 628 pass?

Not yet. PA SB 628 is in committee as of 2025-04-11 and has not come to a final vote. Latest recorded action (2025-04-11): Referred to Health & Human Services

What is PA SB 628 about?

PA SB 628 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for misbranding.”.

Who sponsors PA SB 628?

Amanda Cappelletti is the primary sponsor of PA SB 628, joined by 10 cosponsors.

Introduced: —
Latest action: 2025-04-11 — Referred to Health & Human Services
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2025-04-11
Referred to Health & Human Services
referral-committee

Versions

Printer's No. PN0622Compare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

https://www.palegis.us/legislation/bills/2025/sb628

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:13.705233Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=SB 628. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.